Literature DB >> 15798179

Human progesterone receptor displays cell cycle-dependent changes in transcriptional activity.

Ramesh Narayanan1, Dean P Edwards, Nancy L Weigel.   

Abstract

The human progesterone receptor (PR) contains multiple Ser-Pro phosphorylation sites that are potential substrates for cyclin-dependent kinases, suggesting that PR activity might be regulated during the cell cycle. Using T47D breast cancer cells stably transfected with an mouse mammary tumor virus (MMTV) chloramphenicol acetyltransferase reporter (Cat0) synchronized in different phases of the cell cycle, we found that PR function and phosphorylation is remarkably cell cycle dependent, with the highest activity in S phase. Although PR expression was reduced in the G2/M phase, the activity per molecule of receptor was markedly reduced in both G1 and G2/M phases compared to the results seen with the S phase of the cell cycle. Although PR is recruited to the MMTV promoter equivalently in the G1 and S phases, recruitment of SRC-1, SRC-3, and, consequently, CBP is reduced in G1 phase despite comparable expression levels of SRC-1 and SRC-3. In G2/M phase, site-specific phosphorylation of PR at Ser162 and at Ser294, a site previously reported to be critical for transcriptional activity and receptor turnover, was abolished. Treatment with the histone deacetylase inhibitor trichostatin A elevated G1 and G2/M activity to that of the S phase, indicating that the failure to recruit sufficient levels of active histone acetyltransferase is the primary defect in PR-mediated transactivation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15798179      PMCID: PMC1069605          DOI: 10.1128/MCB.25.8.2885-2898.2005

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  45 in total

1.  FRAP reveals that mobility of oestrogen receptor-alpha is ligand- and proteasome-dependent.

Authors:  D L Stenoien; K Patel; M G Mancini; M Dutertre; C L Smith; B W O'Malley; M A Mancini
Journal:  Nat Cell Biol       Date:  2001-01       Impact factor: 28.824

2.  Phosphorylation of human progesterone receptors at serine-294 by mitogen-activated protein kinase signals their degradation by the 26S proteasome.

Authors:  C A Lange; T Shen; K B Horwitz
Journal:  Proc Natl Acad Sci U S A       Date:  2000-02-01       Impact factor: 11.205

3.  Subnuclear trafficking of estrogen receptor-alpha and steroid receptor coactivator-1.

Authors:  D L Stenoien; M G Mancini; K Patel; E A Allegretto; C L Smith; M A Mancini
Journal:  Mol Endocrinol       Date:  2000-04

4.  E1A-mediated repression of progesterone receptor-dependent transactivation involves inhibition of the assembly of a multisubunit coactivation complex.

Authors:  Y Xu; L Klein-Hitpass; M K Bagchi
Journal:  Mol Cell Biol       Date:  2000-03       Impact factor: 4.272

5.  Differential hormone-dependent phosphorylation of progesterone receptor A and B forms revealed by a phosphoserine site-specific monoclonal antibody.

Authors:  D L Clemm; L Sherman; V Boonyaratanakornkit; W T Schrader; N L Weigel; D P Edwards
Journal:  Mol Endocrinol       Date:  2000-01

6.  Indole-3-carbinol inhibits CDK6 expression in human MCF-7 breast cancer cells by disrupting Sp1 transcription factor interactions with a composite element in the CDK6 gene promoter.

Authors:  E J Cram; B D Liu; L F Bjeldanes; G L Firestone
Journal:  J Biol Chem       Date:  2001-04-10       Impact factor: 5.157

7.  Identification of a phosphorylation site in the hinge region of the human progesterone receptor and additional amino-terminal phosphorylation sites.

Authors:  T A Knotts; R S Orkiszewski; R G Cook; D P Edwards; N L Weigel
Journal:  J Biol Chem       Date:  2000-12-07       Impact factor: 5.157

8.  Cyclin-dependent kinase activity is required for progesterone receptor function: novel role for cyclin A/Cdk2 as a progesterone receptor coactivator.

Authors:  Ramesh Narayanan; Abayomi A Adigun; Dean P Edwards; Nancy L Weigel
Journal:  Mol Cell Biol       Date:  2005-01       Impact factor: 4.272

9.  Cell cycle-dependent glucocorticoid receptor phosphorylation and activity.

Authors:  J M Hu; J E Bodwell; A Munck
Journal:  Mol Endocrinol       Date:  1994-12

10.  Cyclin E as a coactivator of the androgen receptor.

Authors:  A Yamamoto; Y Hashimoto; K Kohri; E Ogata; S Kato; K Ikeda; M Nakanishi
Journal:  J Cell Biol       Date:  2000-08-21       Impact factor: 10.539

View more
  38 in total

Review 1.  Cyclins, cyclin dependent kinases, and regulation of steroid receptor action.

Authors:  N L Weigel; N L Moore
Journal:  Mol Cell Endocrinol       Date:  2007-01-05       Impact factor: 4.102

Review 2.  Cyclin dependent kinase 2 and the regulation of human progesterone receptor activity.

Authors:  Nicole L Moore; Ramesh Narayanan; Nancy L Weigel
Journal:  Steroids       Date:  2007-01-04       Impact factor: 2.668

Review 3.  Integration of progesterone receptor action with rapid signaling events in breast cancer models.

Authors:  Carol A Lange
Journal:  J Steroid Biochem Mol Biol       Date:  2007-09-14       Impact factor: 4.292

Review 4.  Challenges to defining a role for progesterone in breast cancer.

Authors:  Carol A Lange
Journal:  Steroids       Date:  2007-12-28       Impact factor: 2.668

Review 5.  Progesterone and breast cancer.

Authors:  Carol A Lange; Douglas Yee
Journal:  Womens Health (Lond)       Date:  2008-03

6.  p38 and p42/44 MAPKs differentially regulate progesterone receptor A and B isoform stabilization.

Authors:  Junaid A Khan; Larbi Amazit; Catherine Bellance; Anne Guiochon-Mantel; Marc Lombès; Hugues Loosfelt
Journal:  Mol Endocrinol       Date:  2011-08-04

Review 7.  Ecdysteroid hormone action.

Authors:  Klaus-Dieter Spindler; C Hönl; Ch Tremmel; S Braun; H Ruff; M Spindler-Barth
Journal:  Cell Mol Life Sci       Date:  2009-12       Impact factor: 9.261

8.  Switching of chromatin-remodelling complexes for oestrogen receptor-alpha.

Authors:  Maiko Okada; Shin-ichiro Takezawa; Yoshihiro Mezaki; Ikuko Yamaoka; Ichiro Takada; Hirochika Kitagawa; Shigeaki Kato
Journal:  EMBO Rep       Date:  2008-05-02       Impact factor: 8.807

9.  The requirement for p42/p44 MAPK activity in progesterone receptor-mediated gene regulation is target gene-specific.

Authors:  Lindsey S Treviño; William E Bingman; Dean P Edwards; Weigel Nl
Journal:  Steroids       Date:  2013-02-01       Impact factor: 2.668

10.  Partial agonist activity of the progesterone receptor antagonist RU486 mediated by an amino-terminal domain coactivator and phosphorylation of serine400.

Authors:  Suzanne E Wardell; Ramesh Narayanan; Nancy L Weigel; Dean P Edwards
Journal:  Mol Endocrinol       Date:  2009-12-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.